AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
AAPL   383.68 (+0.25%)
MSFT   213.67 (-0.30%)
FB   245.07 (+0.23%)
GOOGL   1,539.01 (+1.34%)
AMZN   3,200.00 (+0.55%)
NVDA   419.17 (-0.28%)
CGC   17.42 (+8.74%)
BABA   261.01 (-0.22%)
MU   50.70 (+1.44%)
GE   6.69 (+1.67%)
TSLA   1,544.65 (+10.78%)
AMD   55.88 (-2.41%)
T   30.13 (+2.00%)
ACB   12.02 (+2.12%)
F   6.10 (+4.27%)
GILD   76.32 (+2.15%)
DIS   119.34 (+2.16%)
BAC   24.02 (+5.49%)
NFLX   548.73 (+8.07%)
BA   178.44 (+2.98%)
Log in

OTCMKTS:HBPCFHelix Biopharma Stock Price, Forecast & News

$0.45
-0.03 (-5.94 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.45
Now: $0.45
$0.45
50-Day Range
$0.47
MA: $0.69
$0.89
52-Week Range
$0.21
Now: $0.45
$1.15
Volume500 shs
Average Volume628 shs
Market Capitalization$59.37 million
P/E RatioN/A
Dividend YieldN/A
Beta-0.13
Helix BioPharma Corp., an immune-oncology company, focuses on the development of cancer drugs in Canada. The company is developing L-DOS47 for the treatment of non-squamous small cell lung cancer, as well as for colon, pancreas, and breast cancer; V-DOS47 that targets the vascular epithelial growth factor receptor 2; and chimeric antigen receptor T-cell (CAR-T) therapeutic for the treatment of hematological and solid tumors. The company has collaboration agreement with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with ProMab Biotechnologies, Inc. to develop novel antibody and chimeric antigen receptor T-cell therapy for hematological malignancies, as well as a collaborative research agreement with Affilogic to assess proprietary anti-tumor targeting agents in combination with DOS47. Helix BioPharma Corp. is headquartered in Richmond Hill, Canada.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:HBPCF
CUSIPN/A
CIKN/A
Phone905-841-2300

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.02) per share

Profitability

Net Income$-5,680,000.00

Miscellaneous

Employees22
Market Cap$59.37 million
Next Earnings Date7/14/2020 (Estimated)
OptionableNot Optionable

Receive HBPCF News and Ratings via Email

Sign-up to receive the latest news and ratings for HBPCF and its competitors with MarketBeat's FREE daily newsletter.

Helix Biopharma (OTCMKTS:HBPCF) Frequently Asked Questions

How has Helix Biopharma's stock been impacted by COVID-19 (Coronavirus)?

Helix Biopharma's stock was trading at $0.97 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, HBPCF stock has decreased by 54.0% and is now trading at $0.4466. View which stocks have been most impacted by Coronavirus.

When is Helix Biopharma's next earnings date?

Helix Biopharma is scheduled to release its next quarterly earnings announcement on Tuesday, July 14th 2020. View our earnings forecast for Helix Biopharma.

Has Helix Biopharma been receiving favorable news coverage?

Headlines about HBPCF stock have trended negative on Friday, InfoTrie Sentiment reports. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Helix Biopharma earned a news sentiment score of -2.4 on InfoTrie's scale. They also gave media stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news about Helix Biopharma.

Who are some of Helix Biopharma's key competitors?

Who are Helix Biopharma's key executives?

Helix Biopharma's management team includes the following people:
  • Dr. Heman Chao, CEO, Chief Scientific Officer, Member of Scientific & Strategic Advisory Board and Director (Age 56)
  • Mr. Photios Michalargias, CFO & Corp. Sec. (Age 56)
  • Mr. Pawel Wisniewski, Chief Exec. Officer of Poland
  • Dr. Trevor Seaton M.D., FRCP(C), Vice Chairman of Medical Advisory Board

What is Helix Biopharma's stock symbol?

Helix Biopharma trades on the OTCMKTS under the ticker symbol "HBPCF."

How do I buy shares of Helix Biopharma?

Shares of HBPCF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Helix Biopharma's stock price today?

One share of HBPCF stock can currently be purchased for approximately $0.45.

How big of a company is Helix Biopharma?

Helix Biopharma has a market capitalization of $59.37 million. Helix Biopharma employs 22 workers across the globe.

What is Helix Biopharma's official website?

The official website for Helix Biopharma is www.helixbiopharma.com.

How can I contact Helix Biopharma?

Helix Biopharma's mailing address is 9120 Leslie Street Suite 205, Richmond Hill A6, L4B3J9. The company can be reached via phone at 905-841-2300 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.